Friends and family often ask me where they should put their money now. I always answer, "Penny pot stocks..." And then emphasize that I'm kidding. But people do love themselves some penny stocks. Investors dream of buying a stock in the low single digits and watching it explode to double digits, making many times their money. However, there are a lot of misconceptions about penny stocks... So once and for all, I'm going to let you in on what is true and false about them. Myth No. 1: Penny stocks have greater potential to double or triple than larger stocks do. Investors believe it's much easier for a $2 stock to become a $4 stock than it is for a stock trading at $100 to rise to $200. Tell that to owners of Tesla (Nasdaq: TSLA)... The stock traded at $211 in September 2019. It climbed to more than $1,000 this month and currently trades well over $900. A stock's price will have no effect on whether it can rise 10%, 20% or 100%. What matters is how much supply and demand there is for the stock. If a small company makes a big announcement but no one is following it, it might be hard to drum up interest in the stock. On the other hand, when an unknown company like Inovio Pharmaceuticals (Nasdaq: INO) suddenly finds itself in the spotlight, the stock can rise from $2 to more than $30, like Inovio did in the past nine months. Myth No. 2: All penny stocks are tiny companies with little revenue or profits. There are quite a few energy companies whose stocks trade for pennies, such as Noble Corp. (NYSE: NE). There are also companies like Acorda Therapeutics (Nasdaq: ACOR), which should have at least $100 million in revenue this year. Sirius XM (Nasdaq: SIRI) has a $1 billion market cap and generated nearly $8 billion in revenue last year. It trades for less than $6. |
No comments:
Post a Comment